small molecule

ACTONEL

RISEDRONATE SODIUM

Loss of exclusivityloss of exclusivity
CompanyALLERGAN PHARMACEUTICALS INTERNATIONAL LTD

Drug detail

Brand nameACTONEL
Active ingredientRISEDRONATE SODIUM
Strength75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2007
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ACTONEL patent cliff — loss of exclusivity — | CliffBio